Tipifarnib is a nonpeptidomimetic quinolinone that binds and inhibits farnesyl protein transferase, blocking protein farnesylation needed for Ras signal transduction. It is studied in squamous cell carcinoma of the head and neck.
Summary written with AI from the sources listed at the end of this page.
At a glance
Also known as
NSC-702818, R-11577, R-115777
Drug type
Small molecule
Targets
farnesyl protein transferase (FNTA)
Mechanism
Inhibitor of farnesyl protein transferase (FNTA)
Pathways
Ras farnesylation and signal transduction, apoptosis, angiogenesis
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z
This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.